Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors: A Case-Control Study
- PMID: 27782199
- PMCID: PMC5080551
- DOI: 10.1038/srep36073
Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors: A Case-Control Study
Abstract
The current study examined risk factors for sporadic pancreatic neuroendocrine tumors (PNETs), including smoking, alcohol use, first-degree family history of any cancer (FHC), and diabetes in the Han Chinese ethnic group. In this clinic-based case-control analysis on 385 patients with sporadic PNETs and 614 age- and sex-matched controls, we interviewed subjects using a specific questionnaire on demographics and potential risk factors. An unconditional multivariable logistic regression analysis was used to estimate adjusted odds ratios (AORs). No significant differences were found between patients and controls in terms of demographic variables. Most of the patients with PNETs had well-differentiated PNETs (G1, 62.9%) and non-advanced European Neuroendocrine Tumor Society (ENETS) stage (stage I or II, 83.9%). Ever/heavy smoking, a history of diabetes and a first-degree FHC were independent risk factors for non-functional PNETs. Only heavy drinking was found to be an independent risk factor for functional PNETs (AOR = 1.87; 95% confidence interval [CI], 1.01-3.51). Ever/heavy smoking was also associated with advanced ENETS staging (stage III or IV) at the time of diagnosis. This study identified first-degree FHC, ever/heavy smoking, and diabetes as risk factors for non-functional PNETs, while heavy drinking as a risk factor for functional PNETs.
References
-
- Turaga K. K. & Kvols L. K. Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin 61, 113–132 (2011). - PubMed
-
- Hauso O. et al.. Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer 113, 2655–2664 (2008). - PubMed
-
- Yao J. C. et al.. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26, 3063–3072 (2008). - PubMed
-
- Fitzgerald T. L., Hickner Z. J., Schmitz M. & Kort E. J. Changing incidence of pancreatic neoplasms: a 16-year review of statewide tumor registry. Pancreas 37, 134–138 (2008). - PubMed
-
- Ito T. et al.. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol 45, 234–243 (2010). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical